147 related articles for article (PubMed ID: 38726288)
1. Transcriptomic analysis of GITR and GITR ligand reveals cancer immune heterogeneity with implications for GITR targeting.
Moussa P; Kurzrock R; Nishizaki D; Miyashita H; Lee S; Nikanjam M; Pabla S; Nesline MK; Ko H; Conroy JM; DePietro P; Sicklick JK; Kato S
Am J Cancer Res; 2024; 14(4):1634-1648. PubMed ID: 38726288
[TBL] [Abstract][Full Text] [Related]
2. Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model.
Song JY; Han MG; Kim Y; Kim MJ; Kang MH; Jeon SH; Kim IA
Radiother Oncol; 2024 Jan; 190():109981. PubMed ID: 37925106
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types.
Zhu MMT; Burugu S; Gao D; Yu J; Kos Z; Leung S; Horst BA; Nielsen TO
Mod Pathol; 2020 Sep; 33(9):1753-1763. PubMed ID: 32350416
[TBL] [Abstract][Full Text] [Related]
4. OX40/OX40 ligand and its role in precision immune oncology.
Thapa B; Kato S; Nishizaki D; Miyashita H; Lee S; Nesline MK; Previs RA; Conroy JM; DePietro P; Pabla S; Kurzrock R
Cancer Metastasis Rev; 2024 Mar; ():. PubMed ID: 38526805
[TBL] [Abstract][Full Text] [Related]
5. GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
Durham NM; Holoweckyj N; MacGill RS; McGlinchey K; Leow CC; Robbins SH
J Immunother Cancer; 2017; 5():47. PubMed ID: 28649380
[TBL] [Abstract][Full Text] [Related]
6. A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist.
Leyland R; Watkins A; Mulgrew KA; Holoweckyj N; Bamber L; Tigue NJ; Offer E; Andrews J; Yan L; Mullins S; Oberst MD; Coates Ulrichsen J; Leinster DA; McGlinchey K; Young L; Morrow M; Hammond SA; Mallinder P; Herath A; Leow CC; Wilkinson RW; Stewart R
Clin Cancer Res; 2017 Jul; 23(13):3416-3427. PubMed ID: 28069723
[No Abstract] [Full Text] [Related]
7. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
8. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
[TBL] [Abstract][Full Text] [Related]
9. Rational design of anti-GITR-based combination immunotherapy.
Zappasodi R; Sirard C; Li Y; Budhu S; Abu-Akeel M; Liu C; Yang X; Zhong H; Newman W; Qi J; Wong P; Schaer D; Koon H; Velcheti V; Hellmann MD; Postow MA; Callahan MK; Wolchok JD; Merghoub T
Nat Med; 2019 May; 25(5):759-766. PubMed ID: 31036879
[TBL] [Abstract][Full Text] [Related]
10. Mature B cells are critical to T-cell-mediated tumor immunity induced by an agonist anti-GITR monoclonal antibody.
Zhou P; Qiu J; L'Italien L; Gu D; Hodges D; Chao CC; Schebye XM
J Immunother; 2010 Oct; 33(8):789-97. PubMed ID: 20842058
[TBL] [Abstract][Full Text] [Related]
11. GITR activation
Gubser C; Pascoe RD; Chang J; Chiu C; Solomon A; Cao R; Rasmussen TA; Lewin SR
iScience; 2023 Nov; 26(11):108165. PubMed ID: 38026168
[TBL] [Abstract][Full Text] [Related]
12. PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITR.
Mizuno R; Maruhashi T; Sugiura D; Shimizu K; Watada M; Okazaki IM; Okazaki T
Biochem Biophys Res Commun; 2019 Apr; 511(3):491-497. PubMed ID: 30771904
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness.
Hirschhorn D; Betof Warner A; Maniyar R; Chow A; Mangarin LM; Cohen AD; Hamadene L; Rizzuto GA; Budhu S; Suek N; Liu C; Houghton AN; Merghoub T; Wolchok JD
JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34676831
[TBL] [Abstract][Full Text] [Related]
14. Role of Thalidomide on the Expression of OX40, 4-1BB, and GITR in T Cell Subsets.
Kim BS; Kim JY; Kim EJ; Lee JG; Joo DJ; Huh KH; Kim MS; Kim YS
Transplant Proc; 2016 May; 48(4):1270-4. PubMed ID: 27320601
[TBL] [Abstract][Full Text] [Related]
15. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality.
Richards DM; Marschall V; Billian-Frey K; Heinonen K; Merz C; Redondo Müller M; Sefrin JP; Schröder M; Sykora J; Fricke H; Hill O; Gieffers C; Thiemann M
J Immunother Cancer; 2019 Jul; 7(1):191. PubMed ID: 31324216
[TBL] [Abstract][Full Text] [Related]
16. The glucocorticoid-induced tumor necrosis factor receptor-related gene modulates the response to Candida albicans infection.
Agostini M; Cenci E; Pericolini E; Nocentini G; Bistoni G; Vecchiarelli A; Riccardi C
Infect Immun; 2005 Nov; 73(11):7502-8. PubMed ID: 16239552
[TBL] [Abstract][Full Text] [Related]
17. Regulation of murine inflammatory bowel disease by CD25+ and CD25- CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells.
Uraushihara K; Kanai T; Ko K; Totsuka T; Makita S; Iiyama R; Nakamura T; Watanabe M
J Immunol; 2003 Jul; 171(2):708-16. PubMed ID: 12847237
[TBL] [Abstract][Full Text] [Related]
18. Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.
You S; Poulton L; Cobbold S; Liu CP; Rosenzweig M; Ringler D; Lee WH; Segovia B; Bach JF; Waldmann H; Chatenoud L
PLoS One; 2009 Nov; 4(11):e7848. PubMed ID: 19936238
[TBL] [Abstract][Full Text] [Related]
19. An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy.
Chan S; Belmar N; Ho S; Rogers B; Stickler M; Graham M; Lee E; Tran N; Zhang D; Gupta P; Sho M; MacDonough T; Woolley A; Kim H; Zhang H; Liu W; Zheng P; Dezso Z; Halliwill K; Ceccarelli M; Rhodes S; Thakur A; Forsyth CM; Xiong M; Tan SS; Iyer R; Lake M; Digiammarino E; Zhou L; Bigelow L; Longenecker K; Judge RA; Liu C; Trumble M; Remis JP; Fox M; Cairns B; Akamatsu Y; Hollenbaugh D; Harding F; Alvarez HM
Nat Cancer; 2022 Mar; 3(3):337-354. PubMed ID: 35256819
[TBL] [Abstract][Full Text] [Related]
20. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells.
Rakké YS; Campos Carrascosa L; van Beek AA; de Ruiter V; van Gemerden RS; Doukas M; Doornebosch PG; Vermaas M; Ter Borg S; van der Harst E; Coene PPLO; Kliffen M; Grünhagen DJ; Verhoef C; IJzermans JNM; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2023; 15(1):77-97. PubMed ID: 36155259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
